跳至主要内容
临床试验/IRCT20240409061460N1
IRCT20240409061460N1招募中Unknown

Comparison of the effect of intravesical injection of Botox with oral tamsulosin 0.4 mg in the treatment of lower urinary tract symptom disorders (LUTS) in patients with symptomatic benign prostatic hyperplasia (BPH).

Ahvaz University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Male

入选标准

  • 1- Prostate volume more than 30 ml
  • 2- Obtaining a score higher than 8 from the International Prostate Symptom Score (IPSS)
  • 3- Serum level total prostate specific antigen (tPSA) less than 10ng/mL
  • 4- maximum urinary flow rate (Qmax) less than 16 ml/s
  • 5- Voided volume (VV) more than 150 ml

排除标准

  • 1- Having an active and recurrent urinary tract infection
  • 2- History of previous prostatectomy
  • 3- History of prostate cancer
  • 4- Bladder or prostate stones
  • 5- History of using phenylephrine, pseudoephedrine, imipramine, cholinergic, anticholinergic, estrogen, androgen and steroid since 4 weeks before the intervention
  • 6- Biopsy from 6 weeks before the intervention
  • 7- History of unstable angina pectoris, primary neurological disease that affects bladder function, such as multiple sclerosis, myasthenia gravis, Parkinson's
  • 8- History of BoNT-A intraprostatic administration
  • 9- Taking ASA, warfarin and NSAIDs from 6 days before the intervention
  • 10- History of bladder sensitivity to BoNT-A

研究者

相似试验